Liver fat content and hepatic insulin sensitivity in overweight patients with type 1 diabetes.

OBJECTIVES Patients with type 1 diabetes mellitus (T1DM) lack the portal/peripheral insulin gradient, which might diminish insulin stimulation of hepatic lipogenesis and protect against development of nonalcoholic fatty liver disease (NAFLD). We compared liver fat content and insulin sensitivity of hepatic glucose production and lipolysis between overweight T1DM patients and nondiabetic subjects. MATERIALS AND METHODS We compared 32 overweight adult T1DM patients and 32 nondiabetic subjects matched for age, body mass index (BMI), and gender. Liver fat content was measured using proton magnetic resonance spectroscopy ((1)H-MRS), body composition by magnetic resonance imaging, and insulin sensitivity using the euglycemic-hyperinsulinemic clamp technique (insulin 0.4 mU/kg · min combined with infusion of D-[3-(3)H]glucose). We also hypothesized that low liver fat might protect from obesity-associated increases in insulin requirements and, therefore, determined insulin requirements across BMI categories in 3164 T1DM patients. RESULTS Liver fat content was significantly lower in T1DM patients than in nondiabetic subjects (0.6% [25th-75th quartiles, 0.3%-1.1%] vs 9.0% [3.0%-18.0%]; P < .001). The endogenous rate of glucose production (R(a)) during euglycemic hyperinsulinemia was significantly lower (0.4 [-0.7 to 0.8] mg/kg fat-free mass · min vs 0.9 [0.2-1.6] fat-free mass · min; P = .012) and the percent suppression of endogenous Ra by insulin was significantly greater (89% [78%-112%] vs 77% [50%-94%]; p = .009) in T1DM patients than in nondiabetic subjects. Serum nonesterified fatty acid concentrations during euglycemic hyperinsulinemia were significantly lower (78.5 [33.0-155.0] vs 306 [200.0-438.0] μmol/L; P < .001) and the percent suppression of nonesterified fatty acids significantly higher (89.1% [78.6%-93.3%] vs 51.4% [36.5%-71.1%]; P < .001) in T1DM patients than in nondiabetic subjects. Insulin doses were similar across BMI categories. CONCLUSIONS T1DM patients might be protected from steatosis and hepatic insulin resistance. Obesity may not increase insulin requirements in T1DM.

[1]  H. Yki-Järvinen.  Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. , 2014, The lancet. Diabetes & endocrinology.

[2]  J. Romijn,et al.  Insulin resistance in multiple tissues in patients with type 1 diabetes mellitus on long‐term continuous subcutaneous insulin infusion therapy , 2013, Diabetes/metabolism research and reviews.

[3]  M. Rewers,et al.  The importance of palmitoleic acid to adipocyte insulin resistance and whole-body insulin sensitivity in type 1 diabetes. , 2013, The Journal of clinical endocrinology and metabolism.

[4]  S. Klein,et al.  Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects. , 2012, Gastroenterology.

[5]  J. Olefsky,et al.  The cellular and signaling networks linking the immune system and metabolism in disease , 2012, Nature Medicine.

[6]  N. Lundbom,et al.  Genetic variation in PNPLA3 (adiponutrin) confers sensitivity to weight loss-induced decrease in liver fat in humans. , 2011, The American journal of clinical nutrition.

[7]  M. Stepanova,et al.  Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[8]  M. Wolzt,et al.  Impaired insulin stimulation of muscular ATP production in patients with type 1 diabetes , 2011, Journal of internal medicine.

[9]  E. Bonora,et al.  Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes. , 2010, Journal of hepatology.

[10]  N. Lundbom,et al.  Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. , 2009, Gastroenterology.

[11]  Alexander Pertsemlidis,et al.  Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease , 2008, Nature Genetics.

[12]  A. Kotronen,et al.  Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. , 2008, Gastroenterology.

[13]  A. Kotronen,et al.  Effect of liver fat on insulin clearance. , 2007, American journal of physiology. Endocrinology and metabolism.

[14]  K. Pietiläinen,et al.  Liver fat in the metabolic syndrome. , 2007, The Journal of clinical endocrinology and metabolism.

[15]  A. Häkkinen,et al.  Effects of insulin therapy on liver fat content and hepatic insulin sensitivity in patients with type 2 diabetes. , 2007, American journal of physiology. Endocrinology and metabolism.

[16]  H. Yki-Järvinen,et al.  Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study , 2006, Diabetologia.

[17]  P. Scifo,et al.  Reduced intrahepatic fat content is associated with increased whole-body lipid oxidation in patients with type 1 diabetes , 2005, Diabetologia.

[18]  Merlin C. Thomas,et al.  Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). , 2005, Diabetes care.

[19]  J. Jessurun,et al.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. , 2005, The Journal of clinical investigation.

[20]  S. Shoelson,et al.  Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB , 2005, Nature Medicine.

[21]  S. Shoelson,et al.  Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. , 2005, Nature medicine.

[22]  H. Beck-Nielsen,et al.  Enhanced hepatic insulin sensitivity, but peripheral insulin resistance in patients with Type 1 (insulin-dependent) diabetes , 1987, Diabetologia.

[23]  A. Häkkinen,et al.  Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. , 2002, The Journal of clinical endocrinology and metabolism.

[24]  R. Hammer,et al.  Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. , 2000, Molecular cell.

[25]  A. Häkkinen,et al.  Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. , 2000, Diabetes.

[26]  H. Yki-Järvinen,et al.  Insulin resistance due to hyperglycaemia: an adaptation protecting insulin-sensitive tissues , 1997, Diabetologia.

[27]  L. Groop,et al.  Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance , 1997, Diabetologia.

[28]  P. Groop,et al.  Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus. , 1996, Circulation.

[29]  H. Yki-Järvinen,et al.  Portal insulin concentrations rather than insulin sensitivity regulate serum sex hormone-binding globulin and insulin-like growth factor binding protein 1 in vivo. , 1995, The Journal of clinical endocrinology and metabolism.

[30]  S. Coppack,et al.  Lack of effect of hyperglycemia on lipolysis in humans. , 1990, The American journal of physiology.

[31]  M. Jensen,et al.  Effects of glucagon on free fatty acid metabolism in humans. , 1991, The Journal of clinical endocrinology and metabolism.

[32]  T. Jenssen,et al.  Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM. , 1990, Diabetes.

[33]  M. Jensen,et al.  Lack of effect of hyperglycemia on lipolysis in humans. , 1990, The American journal of physiology.

[34]  L. Groop,et al.  Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. , 1989, The Journal of clinical investigation.

[35]  H. Yki-Järvinen,et al.  Kinetics of glucose disposal in whole body and across the forearm in man. , 1987, The Journal of clinical investigation.

[36]  H. Yki-Järvinen,et al.  Natural course of insulin resistance in type I diabetes. , 1986, The New England journal of medicine.

[37]  H. Beck-Nielsen,et al.  Glucose transport and metabolism in adipocytes from newly diagnosed untreated insulin-dependent diabetics. Severely impaired basal and postinsulin binding activities. , 1985, The Journal of clinical investigation.

[38]  H. Yki-Järvinen,et al.  Insulin sensitivity in newly diagnosed type 1 diabetics after ketoacidosis and after three months of insulin therapy. , 1984, The Journal of clinical endocrinology and metabolism.

[39]  R. Rizza,et al.  Abnormal meal carbohydrate disposition in insulin-dependent diabetes. Relative contributions of endogenous glucose production and initial splanchnic uptake and effect of intensive insulin therapy. , 1984, The Journal of clinical investigation.

[40]  H. Yki-Järvinen,et al.  Continuous subcutaneous insulin infusion therapy decreases insulin resistance in type 1 diabetes. , 1984, The Journal of clinical endocrinology and metabolism.

[41]  R. DeFronzo,et al.  Splanchnic and renal metabolism of insulin in human subjects: a dose-response study. , 1983, The American journal of physiology.

[42]  P. Cryer,et al.  Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus. , 1982, The Journal of clinical investigation.

[43]  Gerich Je.  Physiology of glucagon. , 1981 .

[44]  J. Gerich,et al.  Physiology of glucagon. , 1981, International review of physiology.

[45]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.

[46]  G. Hetényi,et al.  Glucoregulatory responses in normal and diabetic dogs recorded by a new tracer method. , 1971, Metabolism: clinical and experimental.

[47]  R. Steele,et al.  INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT * , 1959, Annals of the New York Academy of Sciences.